MEC Resources Limited - Panel Receives Application
The Panel has received an application from Grandbridge Limited (ASX:GBA), Trandcorp Pty Ltd and Mr David Breeze in relation to the affairs of MEC Resources Limited (ASX:MMR).
Indiana Resources Limited - Panel Receives Application
The Panel has received an application from Indiana Resources Limited in relation to its affairs.
Spotless Group Holdings Limited - Panel Receives Application
The Panel has received an application from Spotless Group Holdings Limited in relation to its affairs.
ASIC and the Takeovers Panel announce updated Memorandum of Understanding
The Takeovers Panel's Director Allan Bulman and ASIC Commissioner John Price have announced the release of a new Memorandum of Understanding (MOU) between the Panel Executive and ASIC.
Appointment of Panel Members
The Takeovers Panel notes the announcement by the Minister for Revenue and Financial Services of the reappointment of 5 members and the appointment of 6 new members to the Panel, for terms of 3 years commencing on 23 March 2017.
Macmahon Holdings Limited
Introduction
- The Panel, Peter Day, Byron Koster (sitting President) and Karen Phin, declined to conduct proceedings on an application by CIMIC Group Investments Pty Limited and CIMIC Group Limited in relation to the affairs of Macmahon Holdings Limited. The application concerned an off-market takeover bid by CGI for Macmahon. The bidder submitted that certain disclosures by the target were potentially misleading.
Macmahon Holdings Limited - Panel Declines to Conduct Proceedings
The Panel has declined to conduct proceedings on an application dated 6 March 2017 from CIMIC Group Investments Pty Limited and CIMIC Group Limited in relation to the affairs of Macmahon Holdings Limited.
Macmahon Holdings Limited - Panel Receives Application
The Panel has received an application from CIMIC Group Investments Pty Limited and CIMIC Group Limited in relation to the affairs of Macmahon Holdings Limited.
Innate Immunotherapeutics Limited
Introduction
- The Panel, Bruce Cowley, Rodd Levy (sitting President) and Ron Malek declined to conduct proceedings on an application by Mr James Wheeldon in relation to the affairs of Innate Immunotherapeutics Limited. The Application submitted, based on publicly available information, that there was an available inference that a director and shareholder of Innate may be associated with family members and other shareholders and may have obtained effective control of Innate in contravention of section 606 of the Corporations Act 2001 (Cth).
Innate Immunotherapeutics Limited - Panel Declines to Conduct Proceedings
The Panel has declined to conduct proceedings on an application dated 14 February 2017 from Mr James Wheeldon in relation to the affairs of Innate Immunotherapeutics Limited.